H

Hospital Aleman | Department of Cardiology Service

Research site

(Unclaimed)

Location

Avenue Pueyrredon, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Site insights

Top conditions

Top treatments

Carfilzomib

Bemarituzumab

BGB-11417

CC-99282

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma a...

Enrolling

Lymphoma, Non-Hodgkin

Drug: Obinutuzumab

Drug: CC-99282

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression (FORTITUDE-301)

The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.

Enrolling

Solid Tumors

Drug: Bemarituzumab

Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

The study consists of two parts. Part 1 determines the safety and tolerability of BGB-11417 (sonrotoclax) monotherapy, the maximum tolerated dose, an...

Enrolling

Mantle Cell Lymphoma

Relapsed Mantle Cell Lymphoma

Drug: BGB-11417

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms